Home/Pipeline/AKG‑MRSA‑LAI

AKG‑MRSA‑LAI

Methicillin‑resistant Staphylococcus aureus

PreclinicalActive

Key Facts

Indication

Methicillin‑resistant Staphylococcus aureus

Phase

Preclinical

Status

Active

Company

Akagera Medicines

About Akagera Medicines

Rwanda‑based biotech delivering liposomal long‑acting injectables for TB and infectious disease vaccines.

View full company profile

Therapeutic Areas

Infectious Diseases Vaccines